Evaluating use of disease-modifying therapies for multiple sclerosis using claims data. [PDF]
Wang X, Zhao FL, Newby D, Li S.
europepmc +1 more source
Absence of significant hematologic abnormalities in breastfed infants of mothers with multiple sclerosis treated with anti-CD20 therapies. [PDF]
Shah A, Alvarez E.
europepmc +1 more source
Toxicometabolomics Characterization of Two N1-Sulfonated Dimethyltryptamine Derivatives in Zebrafish Larvae and Human Liver S9 Fractions Using Liquid Chromatography-High-Resolution Mass Spectrometry. [PDF]
Punnamraju P +6 more
europepmc +1 more source
Combined Neuroprotective Effects of N,N-Dimethyltryptamine and Ventral Root Reimplantation Following Spinal Root Avulsion in Rats. [PDF]
Aponte PAC +7 more
europepmc +1 more source
Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study. [PDF]
Hedström AK, Olsson T, Alfredsson L.
europepmc +1 more source
Treatment evolution in spinal muscular atrophy: insights from the SMArtCARE registry. [PDF]
Voigt-Müller C +12 more
europepmc +1 more source
Related searches:
Basic research project with rodents. Rodents were administerred DMT and/or harmine and to investigate effects on 5HT2A receptor occupancy of DMT, changes in FDG uptake and brain concentrations of DMT, harmine and their metabolites. This work is published at Frontiers in Pharmacology (DOI: 10.3389/fphar.2023.1140656).
Scheidegger, Milan +2 more
openaire +1 more source

